GKFF
PTCT icon

George Kaiser Family Foundation’s PTC Therapeutics PTCT Stock Holding History

George Kaiser Family Foundation’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,380
Closed -$4.61M – 20
2024
Q1 		$4.61M Hold
24,380
– – 0.87% 5
2023
Q4 		$4.27M Sell
24,380
-21,436
-47% -$490K 0.86% 5
2023
Q3 		$6.49M Sell
45,816
-7,756
-14% -$288K 1.22% 6
2023
Q2 		$7.62M Hold
53,572
– – 1.29% 6
2023
Q1 		$6.87M Sell
53,572
-97
-0.2% -$4.43K 1.11% 7
2022
Q4 		$6.44M Hold
53,669
– – 0.95% 5
2022
Q3 		$5.61M Hold
53,669
– – 0.98% 5
2022
Q2 		$5.71M Hold
53,669
– – 1.01% 6
2022
Q1 		$5.78M Sell
53,669
-18,373
-26% -$708K 0.94% 10
2021
Q4 		$8.73M Sell
72,042
-63
-0.1% -$2.41K 1.25% 5
2021
Q3 		$8.64M Hold
72,105
– – 1.43% 5
2021
Q2 		$10.2M Hold
72,105
– – 1.62% 4
2021
Q1 		$9.93M Sell
72,105
-17,906
-20% -$1.06M 2.07% 5
2020
Q4 		$10.8M Buy
+90,011
New +$5.31M 2.85% 3

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

George Kaiser Family Foundation's PTCT Position: Q2 2024 in Review

George Kaiser Family Foundation sold out of PTC Therapeutics (PTCT) in Q2 2024, closing a stake of 24,380 shares — an estimated $4.61M sold.

George Kaiser Family Foundation first reported a position in PTCT in Q4 2020 and held it in 14 quarters. The position peaked at $10.8M in Q4 2020. 199 funds tracked by Wall St. Rank hold PTCT as of Q2 2024.

  • George Kaiser Family Foundation reported no remaining PTC Therapeutics position as of Q2 2024 after selling out during the quarter.
  • George Kaiser Family Foundation sold 24,380 PTC Therapeutics shares in Q2 2024, an estimated $4.61M.
  • George Kaiser Family Foundation first reported a position in PTC Therapeutics in Q4 2020 and held it in 14 quarters.
  • George Kaiser Family Foundation's PTC Therapeutics position peaked at $10.8M in Q4 2020.
  • 199 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2024.

Based on George Kaiser Family Foundation's 13F filing for Q2 2024, filed 2 Aug 2024.